Non-opioid antinociceptive drugs : risk of respiratory depression and death related to concomitant use of gabapentinoids in addition to opioids

References

• Deeks ED. Mirogabalin: first global approval. Drugs. 2019 [2019 Mar 01];79(4):463–468.
   PubMed Web of Science ®Google Scholar
• Caputo F, Bernardi M. Medications acting on the GABA system in the treatment of alcoholic patients [Review]. Curr Pharm Des. 2010;16(19):2118–2125.
   PubMedGoogle Scholar
• Howland RH. Gabapentin for substance use disorders: is it safe and appropriate? J Psychosoc Nurs Ment Health Serv. 2014 Feb;52(2):13–16.
   Google Scholar
• Bobes J, Rubio G, Teran A, et al. Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice [Research Support, Non-U.S. Gov’t]. Eur Psychiatry. 2012 May;27(4):301–307.
   PubMedGoogle Scholar
• Bramness JG, Sandvik P, Engeland A, et al. Does pregabalin (Lyrica(®)) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian prescription database. Basic Clin Pharmacol Toxicol. 2010 Nov;107(5):883–886.
   PubMedGoogle Scholar
• Oulis P, Konstantakopoulos G. Pregabalin in the treatment of alcohol and benzodiazepines dependence [Review]. CNS Neurosci Ther. 2010;16(1):45–50.
   PubMedGoogle Scholar
• Myhre M, Diep LM, Stubhaug A. Pregabalin has analgesic, ventilatory, and cognitive effects in combination with remifentanil. Anesthesiology. 2016 Jan;124(1):141–149.
   PubMed Web of Science ®Google Scholar
• EMA. PRAC recommendations on signals. Gabapentin has been associated with severe respiratory depression. European Medicine Agency. 2017.
   Google Scholar
• Hill R, Dewey WL, Kelly E, et al. Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition. Br J Pharmacol. 2018 Jun;175(12):2492–2503.
   PubMedGoogle Scholar
• EMA. PRAC-recommendations-signals-adopted-14-17-January-2019. Pregabalin respiratory depression. European Medicine Agency; 2019.
   Google Scholar
• Fuzier R, Serres I, Guitton E, et al. Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database. Drug Saf. 2013 Jan;36(1):55–62.
   PubMed Web of Science ®Google Scholar
• EMCDDA. Annual report on the state of the drugs problem in Europe. Lisbon: EMCDDA; 2010.
   Google Scholar
• Gabapentin and pregabalin: abuse and addiction. Prescrire Int. 2012 Jun;21(128):152–154.
   PubMedGoogle Scholar
• Filipetto FA, Zipp CP, Coren JS. Potential for pregabalin abuse or diversion after past drug-seeking behavior [Case Reports]. J Am Osteopath Assoc. 2010 Oct;110(10):605–607.
   PubMedGoogle Scholar
• Schwan S, Sundstrom A, Stjernberg E, et al. A signal for an abuse liability for pregabalin–results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol. 2010 Sep;66(9):947–953.
   PubMed Web of Science ®Google Scholar
• Caster O, Edwards IR, Noren GN, et al. Earlier discovery of pregabalin’s dependence potential might have been possible [Letter]. Eur J Clin Pharmacol. 2011 Mar;67(3):319–320.
   PubMedGoogle Scholar
• Tambon M, Ponté C, Jouanjus E, et al. Gabapentinoid abuse in France: evidence on health consequences and new points of vigilance. Front Psychiatry. 2021;12:639780.
   PubMed Web of Science ®Google Scholar
• Grosshans M, Lemenager T, Vollmert C, et al. Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol. 2013 Dec;69(12):2021–2025.
   PubMed Web of Science ®Google Scholar
• Driot D, Jouanjus E, Oustric S, et al. Patterns of gabapentin and pregabalin use and misuse: results of a population-based cohort study in France. Br J Clin Pharmacol. 2019 Jun;85(6):1260–1269.
   PubMed Web of Science ®Google Scholar
• Boden R, Wettermark B, Brandt L, et al. Factors associated with pregabalin dispensing at higher than the approved maximum dose. Eur J Clin Pharmacol. 2014 Feb;70(2):197–204.
   PubMed Web of Science ®Google Scholar
• Lyndon A, Audrey S, Wells C, et al. Risk to heroine users of polydrug use of pregabalin or gabapentin. Addiction. 2017 Sep;112(9):1580–1589.
   PubMed Web of Science ®Google Scholar
• Guerrieri D, Rapp E, Roman M, et al. Postmortem and toxicological findings in a series of furanyl fentanyl-related deaths. J Anal Toxicol. 2017 Apr 1;41(3):242–249.
   PubMedGoogle Scholar
• Slavova S, Miller A, Bunn TL, et al. Prevalence of gabapentin in drug overdose postmortem toxicology testing results. Drug Alcohol Depend. 2018 May;1(186):80–85.
   Google Scholar
• Hargrove SL, Bunn TL, Slavova S, et al. Establishment of a comprehensive drug overdose fatality surveillance system in Kentucky to inform drug overdose prevention policies, interventions and best practices. Inj Prev. 2018 Feb;24(1):60–67.
   PubMed Web of Science ®Google Scholar
• Kalk NJ, Chiu CT, Sadoughi R, et al. Fatalities associated with gabapentinoids in England (2004-2020). Br J Clin Pharmacol. 2022 Aug;88(8):3911–3917.
   PubMedGoogle Scholar
• Han A, Durant RW. Gabapentin will not cure the opioid crisis. JAMA Intern Med. 2023;183(2):94 .
   Google Scholar
• Jokinen V, Lilius TO, Laitila J, et al. Pregabalin enhances the antinociceptive effect of oxycodone and morphine in thermal models of nociception in the rat without any pharmacokinetic interactions. Eur J Pain. 2016 Feb;20(2):297–306.
   PubMedGoogle Scholar
• Baird CR, Fox P, Colvin LA. Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers. Eur Addict Res. 2014;20(3):115–118.
   PubMed Web of Science ®Google Scholar
• Vold JH, Skurtveit S, Aas C, et al. Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017. BMC Health Serv Res. 2020 Apr 25;20(1):352.
   PubMedGoogle Scholar
• Fabritius ML, Geisler A, Petersen PL, et al. Gabapentin for post-operative pain management - a systematic review with meta-analyses and trial sequential analyses. Acta Anaesthesiol Scand. 2016 Oct;60(9):1188–1208.
   PubMed Web of Science ®Google Scholar
• Fabritius ML, Strøm C, Koyuncu S, et al. Benefit and harm of pregabalin in acute pain treatment: a systematic review with meta-analyses and trial sequential analyses. Br J Anaesth. 2017 Oct 1;119(4):775–791.
   PubMed Web of Science ®Google Scholar
• Kane CM, Mulvey MR, Wright S, et al. Opioids combined with antidepressants or antiepileptic drugs for cancer pain: systematic review and meta-analysis. Palliat Med. 2018 Jan;32(1):276–286.
   PubMed Web of Science ®Google Scholar
• Verret M, Lauzier F, Zarychanski R, et al. Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. 2020 Aug;133(2):265–279.
   PubMed Web of Science ®Google Scholar
• Wheeler KE, Grilli R, Centofanti JE, et al. Adjuvant analgesic use in the critically ill: a systematic review and meta-analysis. Crit Care Explor. 2020 Jul;2(7):e0157.
   PubMedGoogle Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583.
   PubMed Web of Science ®Google Scholar
• Eipe N, Penning J. Postoperative respiratory depression with pregabalin: a case series and a preoperative decision algorithm. Pain Res Manag. 2011 Sep-Oct;16(5):353–356.
   PubMed Web of Science ®Google Scholar
• Singh H, Handa R, Kak V, et al. Complex encephalopathy arising from the combination of opioids and gabapentin. BMJ Case Reports CP. 2019;12(4):e228354.
   PubMedGoogle Scholar
• Lee C, Wanson A, Frangou S, et al. Opioid toxicity due to CNS depressant polypharmacy: a case report. Ment Health Clin. 2021 Mar;11(2):70–74.
   PubMedGoogle Scholar
• Sastre C, Baillif-Couniou V, Fabresse N, et al. Mésusage de prégabaline: à propos de sept cas de décès en région marseillaise. Toxicologie Analytique et Clinique. 2022;34(3):151–158 .
   Google Scholar
• Desai PH, Taylor O, Shah KJ, et al. Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids. Ment Health Clin. 2021 Jul;11(4):225–230.
   PubMedGoogle Scholar
• Madden K, Haider A, Rozman De Moraes A, et al. Frequency of concomitant use of gabapentinoids and opioids among patients with cancer-related pain at an outpatient palliative care clinic. J Palliat Med. 2021 Jan;24(1):91–96.
   PubMedGoogle Scholar
• Gomes T, Juurlink DN, Antoniou T, et al. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017 Oct;14(10):e1002396.
   PubMed Web of Science ®Google Scholar
• Gomes T, Greaves S, van den Brink W, et al. Pregabalin and the risk for opioid-related death: a nested case-control study. Ann Intern Med. 2018 Nov 20;169(10):732–734.
   PubMed Web of Science ®Google Scholar
• Chen TC, Knaggs RD, Chen LC. Association between opioid-related deaths and prescribed opioid dose and psychotropic medicines in England: a case-crossover study. Br J Anaesth. 2021 Nov;127(5):789–797.
   PubMed Web of Science ®Google Scholar
• Chen TC, Knaggs RD, Chen LC. Association between opioid‐related deaths and persistent opioid prescribing in primary care in England: a nested case‐control study. Br J Clin Pharmacol. 2022;88(2):798–809.
   PubMedGoogle Scholar
• Weingarten TN, Jacob AK, Njathi CW, et al. Multimodal analgesic protocol and postanesthesia respiratory depression during phase I recovery after total joint arthroplasty [Article]. Reg Anesth Pain Med. 2015 Jul-Aug;40(4):330–336.
   PubMed Web of Science ®Google Scholar
• Abrahamsson T, Berge J, Öjehagen A, et al. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study. Drug Alcohol Depend. 2017 May;1(174):58–64.
   Google Scholar
• Cavalcante AN, Sprung J, Schroeder DR, et al. Multimodal analgesic therapy with gabapentin and its association with postoperative respiratory depression. Anesth Analg. 2017 Jul;125(1):141–146.
   PubMed Web of Science ®Google Scholar
• Savelloni J, Gunter H, Lee KC, et al. Risk of respiratory depression with opioids and concomitant gabapentinoids. J Pain Res. 2017;10:2635–2641.
   PubMed Web of Science ®Google Scholar
• Peckham AM, Fairman KA, Sclar DA. All-cause and drug-related medical events associated with overuse of gabapentin and/or opioid medications: a retrospective cohort analysis of a commercially insured US population. Drug Saf. 2018 Feb;41(2):213–228.
   PubMed Web of Science ®Google Scholar
• Macleod J, Steer C, Tilling K, et al. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLoS Med. 2019 Nov;16(11):e1002965.
   PubMedGoogle Scholar
• Ohnuma T, Krishnamoorthy V, Ellis AR, et al. Association ‘between gabapentinoids on the day of colorectal surgery and adverse postoperative respiratory outcomes [Article]. Ann Surg. 2019 Dec;270(6):e65–e67.
   PubMed Web of Science ®Google Scholar
• Bykov K, Bateman BT, Franklin JM, et al. Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States. JAMA Network Open. 2020 Dec 1;3(12):e2031647.
   PubMed Web of Science ®Google Scholar
• Waddy SP, Becerra AZ, Ward JB, et al. Concomitant use of gabapentinoids with opioids is associated with increased mortality and morbidity among dialysis patients. Am J Nephrol. 2020;51(6):424–432.
   PubMedGoogle Scholar
• Ohnuma T, Raghunathan K, Moore S, et al. Dose-dependent association of gabapentinoids with pulmonary complications after total hip and knee arthroplasties. J Bone Joint Surg Am. 2020 Feb 5;102(3):221–229.
   PubMed Web of Science ®Google Scholar
• Tan HS, Frere Z, Krishnamoorthy V, et al. Association of gabapentinoid utilization with postoperative pulmonary complications in gynecologic surgery: a retrospective cohort study. Curr Med Res Opin. 2021 May;37(5):821–828.
   PubMed Web of Science ®Google Scholar
• Wachtendorf LJ, Schaefer MS, Santer P, et al. Association between preoperative administration of gabapentinoids and 30-day hospital readmission: a retrospective hospital registry study. J Clin Anesth. 2021;73:110376.
   PubMedGoogle Scholar
• Zhou L, Bhattacharjee S, Kwoh CK, et al. Dual-trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study. Addiction. 2021 Apr;116(4):819–830.
   PubMedGoogle Scholar
• McGauvran MM, Ohnuma T, Raghunathan K, et al. Association between gabapentinoids and postoperative pulmonary complications in patients undergoing thoracic surgery [Article]. J Cardiothorac Vasc Anesth. 2022;36(8):2295–2302.
   PubMedGoogle Scholar
• Garcia RM, Cassinelli EH, Messerschmitt PJ, et al. A multimodal approach for postoperative pain management after lumbar decompression surgery: a prospective, randomized study. J Spinal Disord Tech. 2013 Aug;26(6):291–297.
   PubMedGoogle Scholar
• Torrance N, Veluchamy A, Zhou Y, et al. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. Br J Anaesth. 2020 Aug;125(2):159–167.
   PubMed Web of Science ®Google Scholar
• Lynn E, Cousins G, Lyons S, et al. A repeated cross-sectional study of factors associated with pregabalin-positive poisoning deaths in Ireland. Drug Alcohol Depend. 2020 1;Jan(206):107741.
   Google Scholar
• Isoardi KZ, Polkinghorne G, Harris K, et al. Pregabalin poisoning and rising recreational use: a retrospective observational series. Br J Clin Pharmacol. 2020 Dec;86(12):2435–2440.
   PubMed Web of Science ®Google Scholar
• Kriikku P, Ojanpera I. Pregabalin and gabapentin in non-opioid poisoning deaths. Forensic Sci Int. 2021 Jul;324:110830.
   PubMedGoogle Scholar
• Kumar AH, Habib AS. The role of gabapentinoids in acute and chronic pain after surgery. Curr Opin Anaesthesiol. 2019 Oct;32(5):629–634.
   PubMed Web of Science ®Google Scholar
• Aurilio C, Pace MC, Sansone P, et al. Multimodal analgesia in neurosurgery: a narrative review. Postgrad Med. 2022 Apr;134(3):267–276.
   PubMedGoogle Scholar
• Derogatis MJ, Sodhi N, Anis HK, et al. Pain management strategies to reduce opioid use following total knee arthroplasty. Surg Technol Int. 2019 Nov;10(35):301–310.
   Google Scholar
• Hannon CP, Fillingham YA, Browne JA, et al. The efficacy and safety of gabapentinoids in total joint arthroplasty: systematic review and direct meta-analysis. J Arthroplasty. 2020 Oct;35(10):2730–2738 e6.
   PubMedGoogle Scholar
• Patel AS, Abrecht CR, Urman RD. Gabapentinoid use in perioperative care and current controversies. Curr Pain Headache Rep. 2022 Feb;26(2):139–144.
   PubMedGoogle Scholar
• Seib RK, Paul JE. Preoperative gabapentin for postoperative analgesia: a meta-analysis [Article]. Can J Anaesth. 2006;53(5):461–469.
   PubMed Web of Science ®Google Scholar
• Zakkar M, Frazer S, Hunt I. Is there a role for gabapentin in preventing or treating pain following thoracic surgery? [Article]. Interact Cardiovasc Thorac Surg. 2013 Oct;17(4):716–719.
   PubMedGoogle Scholar
• Macfater H, Xia W, Srinivasa S, et al. Evidence-based management of postoperative pain in adults undergoing laparoscopic sleeve gastrectomy. World J Surg. 2019 Jun;43(6):1571–1580.
   PubMedGoogle Scholar
• Chaparro LE, Smith SA, Moore RA, et al. Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev. 2013;2013(7):CD008307. doi:10.1002/14651858.CD008307.pub2.
   Google Scholar